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Background: To determine frequency of febrile 
neutropenia episodes (FN) in patients of acute 
lymphoblastic leukaemia (ALL) on chemotherapy 
and to study different type of organisms isolated in 
them along with their sensitivity to different 
antibiotics. 
Methods: In this descriptive study children of 
either gender diagnosis of ALL and  on any one of 
the initial four phase of chemotherapy including 
induction, consolidation, interim maintenance and 
delayed intensification were followed prospectively 
from start till end of that particular phase. The 
chemotherapy protocol used in the centre is BFM 
protocol. Patients who developed fever (≥ 38°C) 
during this time and turned out to be neutropenic 
(ANC ≤ 500/mm3) underwent  blood culture(on 
Bectec). Antimicrobial susceptibility profile was 
done by Kirby Bauer disc diffusion method on 
Muller Hinton agar,according to CLSI 2006 
guidelines.  
Results: Mean age of children was 5.5(±3.0) years. 
Of 94 ALL patients enrolled in the current study, 
46% were younger than 5 years and 73% were males. 
Out of 94  37 (39%) developed fever and neutropenia. 
The  mean (SD) temperature of all the children was 
38.9 (±0.3)0C. The mean (SD) absolute neutrophil 
count (ANC) was 264.0 (±149.2)/mm3. Out of 37 
children who developed febrile neutropenia, 25% 
had positive blood cultures. The most common 
isolate was Klebsiella (44.4%), followed by 
Pseudomonas aeruginosa (33.3%) and 
Staphylococcus aureas (22.2%). Klebsiella was 
sensitive to most of the antibiotics tested except 
cephalosporins. Sensitivity of pseudomonas was 
100% to ceftazidime and cefotaxime while Staph. 
aureas was 100% sensitive to ceftazidime, imipenem 
and ciprofloxacin. 
Conclusion: Nearly two-fifths of the children with 
ALL developed febrile neutropenia. A quarter of 
them showed positive blood cultures. The most 
common pathogen found in our study was 
Klebsiella, followed by Pseudomonas and 
Staphylococcus aureus. Most of the antibiotics tested 
for the Klebsiella were shown to be effective except 
cephalosporins. For Pseudomonas, Cefrazidine and 
Cefotaxime were 100% sensitive, while for 
Staphylococcus Cefrazidine, Imipenem and 
Ciprofloxacine showed 100% sensitivity. 




Virtually all chemotherapy regimens can produce 
myelosupression and neutropenia (absolute neutrophil 
count < 500/mm3).1,2 It poses a risk of life threatening 
infection in cancer patients. Prevalence of FN in ALL 
patients is 42% , representing significant disease 
burden thus need for monitoring patients receiving 
chemotherapy for fever and neutropenia cannot be 
overemphasized. 3 In  a case, where  fever 
(temperature ≥ 38°C)1 and neutropenia occurs during 
treatment course, immediate assessment and treatment 
is required . 1 
Time to antibiotic administration (TTA) is found   
independently associated with mortality within 28 
days and each increase of 1 hour in TTA raised risk of 
mortality within 28 days by 18%.4 It is important to 
determine etiology of FN to give prompt pathogen 
specific regimen in order to reduce mortality and 
morbidity. As bacterial etiology of FN is changing with 
time and with the emergence of newer antibiotics as 
well as it is different in different geographical areas, 
the clinician must have knowledge of the prevalence of 
causative bacteria and their antibiotic sensitivity in 
these patients so that appropriate empirical therapy  
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can be given. This study assessed the frequency of FN 
in ALL patients receiving chemotherapy as well as the 
type and isolation rate of causative bacterial agents 
and their sensitivity pattern in our region thus will be 
helpful in improving treatment modalities. 
 
Patients and Methods 
This descriptive study was carried out from 
September, 2011 to February, 2012 at oncology 
department of Children Hospital PIMS. All children of 
either gender admitted in ward with diagnosis of ALL 
and were on any one of the initial four phase of 
chemotherapy including induction, consolidation, 
interim maintenance and delayed intensification were 
followed prospectively from start till end of that 
particular phase. The chemotherapy protocol used in 
the centre is BFM protocol. Patients who developed 
fever (≥ 38°C) during this time, their blood samples 
were sent to lab for cell counts and those who turned 
out to be neutropenic (ANC ≤ 500/mm3) their blood 
sample was collected for bacterial culture study in 
Bactec blood culture bottles and were proceeded 
through automated blood culturing system (Bactec 
9050, BD, USA). Antimicrobial susceptibility profile 
was done by Kirby Bauer disc diffusion method on 
Muller Hinton agar using antibiotic discs of commonly 
used antimicrobial agents according to CLSI 2006 
guidelines5. Culture and sensitivity results were 
recorded. 
Results 
Majority (73%) were males. The age ranged between 1-
12 years. Amongst children with febrile neutropenia, 
out of 37 children, 15 (40.5%) children were less than 5 
years of age, 21 (56.8%) were aged between 5 and 9 
years while 1 (2.7%) child was aged 10 years. Whereas, 
of 57 children without febrile neutropenia, 28 (49.1%) 
were aged less than 5 years, 21 (36.8%) and 8 (14%) 
were 5 to 9 and 10 and more years of age respectively. 
The difference in the distribution of age categories 
between children who had febrile neutropenia and 
those who did not have it was not statistically 
significant (p=0.068).The mean (SD) absolute 
neutrophil count (ANC) was 264.0 (±149.2)/mm3 with 
median and mode of 253.0/mm3 and 200.0/mm3 
respectively. The range of absolute neutrophil count 
was between 0 and 500/mm3  (Table 1). Out of 94 
children 37 (39%) were diagnosed to have febrile 
neutropenia. No statistically significant difference was 
seen between those who developed and who did not 
develop febrile neutropenia regarding the phases of 
chemotherapy (p=0.060) (Table 2). Out of 37 children 
who developed febrile neutropenia, 9 (25%) had 
positive blood cultures. Of 37 children with febrile 
neutropenia, 4 (44.4%) cultures showed growth of 
Klebseilla, 3 (33.3%) showed growth of Pseudomonas 
and 2 (22.2%) cultures showed growth of 
Staphylococcus aureus (Table 3). 
 
Table 1 - Distribution of absolute neutrophil 
count by phases of chemotherapy (n=94) 
Variable Absolute neutrophil count 
Mean 
(SD) 





















246.0 (0 – 500) 
 
Table 2: Comparison of distribution of phase of 
chemotherapy between those who had and 






















Consolidation 11 13 24 46% 
Interim 
maintenance 
3 17 20 15% 
Delayed 
intensification 
10 9 19 53% 
 
Table 3 - Antibiotic sensitivity and resistant 
pattern (in percentage) of various pathogens in 
blood positive children  







Amikacin 100.0% 0.0% 0.0% 100.0% 0.0% 100.0% 
Ceftriaxone  25.0% 75.0% 0.0% 100.0% 0.0% 100.0% 
Ceftazidine 50% 50% 100.0% 0.0% 0.0% 100.0% 
Cefuroxime 0.0% 100.0% 0.0% 100.0% 100.0% 0.0% 
Cefotaxime 0.0% 100.0% 100.0% 0.0% 0.0% 100.0% 
Imipenem 100.0% 0.0% 66.6% 33.3% 100.0% 0.0% 
Levofloxacin 100.0% 0.0% 0.0% 100.0% 0.0% 100.0% 
Augmentin 100.0% 0.0% 0.0% 100.0% 0.0% 100.0% 
Ciprofloxacin 100.0% 0.0% 0.0% 100.0% 100.0% 0.0% 
Piperacillin 100.0% 0.0% 0.0% 100.0% 0.0% 100.0% 
Tobramycin 100.0% 0.0% 0.0% 100.0% 0.0% 100.0% 
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Discussion 
Febrile neutropenia is a common problem in children 
being treated for oncological diseases. Epidemiological 
studies have demonstrated a high incidence of sepsis 
in paediatric patients receiving chemotherapy, shown 
to be approximately 12.8% in children age 1-9 years 
and 17.4% in children aged 10-19 years, making febrile 
neutropenia a worrying and serious complication.6  
Comparison of  present study results ,with those 
published by other centers in the world, has shown 
many similar, and a few different findings.7,8,9In a 
study conducted in New Dehli India on febrile 
neutropenia in ALL patients blood cultures were 
positive in 31% cases. Among them 67% were due to 
gram negative organisms and 33% due to gram 
positive organisms showing predominance of gram 
negative like our study. E-coli was the commonest 
isolate (45.7%) in gram negative and Staphylococcus 
aureus was commonest (39%) in gram positive 
organisms.7 A German study having 14.6% organism 
isolation rate showed contrasting results to ours with 
gram positive organisms being predominant (61%) 
and 36% gram negative.10 A prospective cohort study 
from Italy demonstrated a higher prevalence of gram 
negative bacteria as compared to gram positive and 
mortality was also significantly higher from gram 
negative bacterial infections (16.9% vs 5.6%).11 Another 
study from Pakistan in which gram negative cultures 
were studied, pseudomonas was the most common 
(38%) and the resistance pattern of pseudomonas and 
enterobacteraceae against cefepime, meropenem, 
ciprofloxacin, ceftriaxone, tobramycin, cefoperazone 
and imipenem were 60%, 13%, 80%, 67%, 40%, 90%, 
10% and 80%, 20%, 88%, 72%, 20%, 90% and 4% 
respectively.12 Among all the phases of chemotherapy 
highest rate of febrile neutropenia occurred in 
induction phase in our study (35%) as this phase is 
most intensive. Similar pattern is reported in above 
mentioned Indian study conducted in Dehli where 
45.25% infections occurred in induction phase.7  
There were major changes in type and range of 
pathogens causing infection in neutropenic patients 
during last decades. Gram-negative organisms were 
more prevalent in the first decade following 
introduction of chemotherapy for leukemia. During 
1980s and early 1990s gram positive pathogens 
increased. With beginning of new century, gram-
negative bacilli have re-emerged and there is rapid 
increase in antimicrobial resistance as well.13  
As bacterial etiology of febrile neutropenia is changing 
with time and it is different in different geographical 
areas, the clinician must have knowledge of the 
prevalence of causative bacteria and their antibiotic 
sensitivity in these patients so that appropriate 
empirical treatment can be given. This study assessed 
the type and isolation rate of causative bacterial agents 
and their sensitivity pattern in our hospital and thus 
will be helpful in improving treatment modalities. 
From the current study, we should stress the 
importance of frequent reviewing of the type, 
frequency, severity and outcome of infectious 
complications, in such critically ill patients over the 
years in order to detect changing epidemiologic 
patterns.One of the criteria established in the 
management of febrile neutropenia is the absolute 
neutrophil count at presentation.  ANC counts < 0. 2 x 
109/L are found to be associated with a higher risk of 
infection and bacterial sepsis.14  Similar association was 
observed in the present study.  
 
Conclusions 
1. Nearly two-fifths of the children with ALL 
enrolled in the current study developed febrile 
neutropenia.  Among children who had developed 
febrile neutropenia, a quarter of them showed 
positive blood cultures. The most common 
pathogen found in our study was Klebsiella, 
followed by Pseudomonas and Staphylococcus 
aureus. 
2.  Most of the antibiotics tested for the Klebsiella 
were shown to be effective except cephalosporins. 
For Pseudomonas, Cefrazidine and Cefotaxime 
were 100% sensitive, while for Staphylococcus 
Cefrazidine, Imipenem and Ciprofloxacin showed 
100% sensitivity.    
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